X

Xponance Portfolio holdings

AUM $12.6B
1-Year Est. Return 31%
This Quarter Est. Return
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12B
AUM Growth
+$1.63B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,552
New
Increased
Reduced
Closed

Top Buys

1 +$42.5M
2 +$40.7M
3 +$39.9M
4
GE icon
GE Aerospace
GE
+$22.6M
5
ABBV icon
AbbVie
ABBV
+$20M

Top Sells

1 +$22.1M
2 +$21.8M
3 +$19M
4
CRM icon
Salesforce
CRM
+$16.1M
5
MRK icon
Merck
MRK
+$15.5M

Sector Composition

1 Technology 37.5%
2 Financials 11.85%
3 Consumer Discretionary 11.39%
4 Communication Services 10.18%
5 Healthcare 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERAS icon
1501
Erasca
ERAS
$1B
$17.1K ﹤0.01%
13,490
+374
PGEN icon
1502
Precigen
PGEN
$1.51B
$16.4K ﹤0.01%
+11,546
DDD icon
1503
3D Systems Corp
DDD
$259M
$15.7K ﹤0.01%
10,165
-417
ESPR icon
1504
Esperion Therapeutics
ESPR
$875M
$15.2K ﹤0.01%
15,471
+1,530
ALLO icon
1505
Allogene Therapeutics
ALLO
$294M
$13.3K ﹤0.01%
+11,805
HYLN icon
1506
Hyliion Holdings
HYLN
$334M
$13.3K ﹤0.01%
10,047
-1,393
IRWD icon
1507
Ironwood Pharmaceuticals
IRWD
$542M
$8.85K ﹤0.01%
12,339
+846
WOLF icon
1508
Wolfspeed
WOLF
$443M
$4.94K ﹤0.01%
+12,380
ACLX icon
1509
Arcellx
ACLX
$3.68B
-3,278
AGO icon
1510
Assured Guaranty
AGO
$4.18B
-2,347
AUPH icon
1511
Aurinia Pharmaceuticals
AUPH
$2.09B
-10,146
CASH icon
1512
Pathward Financial
CASH
$1.61B
-3,903
CCOI icon
1513
Cogent Communications
CCOI
$1.07B
-3,497
CCO icon
1514
Clear Channel Outdoor Holdings
CCO
$1.07B
-25,448
CHPT icon
1515
ChargePoint
CHPT
$159M
-1,672
DFS
1516
DELISTED
Discover Financial Services
DFS
-35,768
DHT icon
1517
DHT Holdings
DHT
$1.95B
-10,113
DXC icon
1518
DXC Technology
DXC
$2.59B
-14,032
EAF icon
1519
GrafTech
EAF
$402M
-1,817
FIVN icon
1520
FIVE9
FIVN
$1.56B
-9,835
HEES
1521
DELISTED
H&E Equipment Services
HEES
-2,444
HP icon
1522
Helmerich & Payne
HP
$2.85B
-8,294
IAUX
1523
i-80 Gold Corp
IAUX
$1.25B
-22,498
JWN
1524
DELISTED
Nordstrom
JWN
-15,907
LCTX icon
1525
Lineage Cell Therapeutics
LCTX
$369M
-12,875